Explain the mechanism of acute respiratory distress syndrome

Reading File

Finding Sources

Searching PubMed

"acute respiratory distress syndrome"[MeSH Terms] AND pathogenesis

Reading File

Finding Sources

Reading File

I now have comprehensive source material on ARDS mechanism. Let me compile the full detailed answer.

Mechanism of Acute Respiratory Distress Syndrome (ARDS)

Definition and Core Concept

ARDS is a syndrome of acute, diffuse inflammatory lung injury resulting in increased alveolar-capillary permeability, loss of aerated lung tissue, and refractory hypoxemia. Unlike cardiogenic pulmonary edema (driven by elevated left-sided cardiac pressures and hydrostatic forces), ARDS produces exudative, protein-rich edema because the alveolar-capillary barrier itself is disrupted. This is the fundamental pathophysiologic distinction.

The Berlin criteria define ARDS as:

Bilateral opacities on chest radiograph/CT not explained by effusions or collapse
PaO2/FiO2 ratio <300 mmHg on at least 5 cmH2O PEEP (mild <300, moderate <200, severe <100)
Onset within 7 days of a known clinical insult
Not fully explained by cardiac failure or fluid overload

Etiology: Direct vs. Indirect Lung Injury

Inciting causes are classified by mechanism of injury:

Direct (Pulmonary)	Indirect (Nonpulmonary)
Pneumonia (bacterial, viral, COVID-19)	Sepsis
Aspiration	Major trauma
Pulmonary contusion	Multiple blood transfusions (TRALI)
Toxic inhalation	Pancreatitis
Near-drowning	Cardiopulmonary bypass
Reperfusion injury (post-transplant)	Drug overdose

The most common triggers are sepsis and pneumonia. Regardless of the trigger, the downstream inflammatory cascade follows a common final pathway.

Murray & Nadel's Textbook of Respiratory Medicine, p. 3145

Pathogenesis: The Core Cascade

1. Initial Insult and Neutrophil Recruitment

The central cellular mediator of ARDS is the polymorphonuclear neutrophil (PMN). Following the inciting event:

Circulating PMNs are primed and activated, then sequestered in the pulmonary microcirculation.
They transmigrate across the alveolar-capillary membrane into the interstitium and airspaces.
Once activated within the lung, PMNs release a destructive arsenal:
- Proteases (elastase, matrix metalloproteinases) - degrade structural matrix proteins and surfactant-associated proteins
- Reactive oxygen species (ROS) - cause direct oxidative membrane damage
- Cytokines and chemokines (TNF-α, IL-1β, IL-6, IL-8) - amplify local and systemic inflammation
- Neutrophil extracellular traps (NETs) - web-like chromatin structures that contribute to microvascular occlusion and further tissue injury
- Platelet-activating factor (PAF) - increases vascular permeability

Neutrophil elastase specifically degrades surfactant protein A, compounding surfactant dysfunction.

Murray & Nadel's Textbook of Respiratory Medicine, p. 3147

2. Alveolar-Capillary Barrier Disruption

The barrier has two components, both of which are injured:

Microvascular endothelium: Loss of endothelial barrier integrity is both necessary and sufficient for ARDS. Endothelial injury leads to increased permeability, allowing protein-rich fluid to leak into the interstitium and then the alveolar spaces. Mechanisms include:

Apoptosis triggered by cytokines and ROS
Direct cytotoxic injury from proteases
Disruption of inter-endothelial tight junctions

Alveolar epithelium: Damage to alveolar epithelial cells (particularly type I pneumocytes, which cover ~95% of the alveolar surface) is a key precipitating event. It contributes via:

Loss of barrier integrity - allows fluid flooding of airspaces
Loss of alveolar fluid clearance - normally driven by active sodium/chloride transport across epithelium, this mechanism fails in ARDS
Type II pneumocyte injury - reduces synthesis of surfactant

Multiple mechanisms of cell death operate simultaneously: necrosis, apoptosis, coagulation-mediated injury, and mechanical stretch injury (from over-distension during ventilation).

Murray & Nadel's Textbook of Respiratory Medicine, p. 3146

3. Surfactant Dysfunction

Surfactant (produced by type II pneumocytes) normally reduces alveolar surface tension and prevents collapse at end-expiration. In ARDS:

Type II cell injury reduces surfactant synthesis
Neutrophil elastase degrades surfactant protein A
Protein-rich edema fluid dilutes and inactivates surfactant
Phospholipase A2 (from pancreatic enzymes in pancreatitis-associated ARDS) directly degrades surfactant

The result is markedly increased alveolar surface tension, leading to widespread microatelectasis and reduced compliance.

4. Cytokine Storm and Amplification Loop

Pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8) released by macrophages and activated PMNs create a self-amplifying loop:

Recruit more neutrophils (IL-8 is a potent PMN chemoattractant)
Activate endothelial cells, upregulating adhesion molecules (ICAM-1, E-selectin) that further promote neutrophil margination
Activate the coagulation cascade (intravascular fibrin deposition contributes to pulmonary hypertension)
May spill systemically, driving multi-organ dysfunction syndrome (MODS)

5. Coagulation Abnormalities

ARDS involves a shift toward a procoagulant, antifibrinolytic state in the alveolar compartment:

Tissue factor expressed on damaged epithelium and macrophages activates the extrinsic coagulation pathway
Intravascular and intraalveolar fibrin deposition occurs
Fibrin in alveoli forms the framework for hyaline membrane deposition
This contributes to pulmonary hypertension through microvascular occlusion

Pathological Phases

The histologic pattern is called Diffuse Alveolar Damage (DAD), and it progresses through three overlapping phases:

Phase 1 - Exudative (Days 1-7)

Protein-rich edema floods alveoli
Hyaline membrane formation (cellular debris + proteins + surfactant remnants lining alveolar walls)
Widespread epithelial disruption
Heavy neutrophil infiltration of interstitium and airspaces

Phase 2 - Proliferative (Days 7-21)

Hyaline membranes reorganized
Type II pneumocyte proliferation (attempt at regeneration)
Fibroblast infiltration begins
Collagen deposition starts
Decrease in neutrophil numbers

Phase 3 - Fibrotic (>2-3 weeks)

Pulmonary fibrosis in a subset of patients
Obliteration of pulmonary capillaries
Interstitial and alveolar collagen deposition
Notably, fibroproliferation may begin as early as 24 hours after onset (elevated N-terminal procollagen peptide III detectable in BAL fluid from day 1)

Important caveat: Only ~50% of patients meeting clinical ARDS criteria show DAD on autopsy/biopsy. Those with DAD tend to be younger, more severely ill, with lower P/F ratios and higher mortality.

Murray & Nadel's Textbook of Respiratory Medicine, p. 3146

Resulting Pathophysiology

The cascade above produces four major physiologic derangements:

Derangement	Mechanism
Hypoxemia	Alveolar flooding causes ventilation-perfusion (V/Q) mismatch and right-to-left intrapulmonary shunting
Reduced compliance	Surfactant loss, atelectasis, alveolar edema, and fibrosis stiffen the lung ("baby lung" phenomenon)
Increased dead space	Microvascular thrombosis and obliteration reduce perfusion to ventilated units
Pulmonary hypertension	Hypoxic vasoconstriction, intravascular fibrin, compression by positive-pressure ventilation

The gravitational distribution of lesions is important: the heavy, edematous lung behaves like a sponge, with dependent zones consolidated/fluid-filled and nondependent zones remaining relatively aerated (the "baby lung").

Summary Diagram of Mechanism

Inciting event (sepsis, pneumonia, trauma, aspiration...)
          ↓
Systemic/local inflammatory activation
          ↓
Neutrophil priming → sequestration in pulmonary microcirculation
          ↓
PMN transmigration into alveolar-capillary space
          ↓
Release of: proteases, ROS, cytokines, NETs, PAF
          ↓
┌──────────────────────────────────────────────┐
│ Endothelial injury    │  Epithelial injury    │
│ ↓ barrier integrity   │  Type I cell necrosis │
│ protein-rich leak     │  Type II cell injury  │
│                       │  ↓ fluid clearance    │
│                       │  ↓ surfactant         │
└──────────────────────────────────────────────┘
          ↓
Alveolar flooding → hyaline membranes → DAD
          ↓
V/Q mismatch + shunt → refractory hypoxemia
Reduced compliance → increased work of breathing
Pulmonary HTN → dead space ↑
          ↓
Cytokine spillover → MODS

Murray & Nadel's Textbook of Respiratory Medicine (Murray & Nadel), pp. 3145-3149
Goldman-Cecil Medicine, p. 1066
Sabiston Textbook of Surgery, p. 940

This is a shared conversation. Sign in to Orris to start your own chat.